Filing Flows

Filing Flows › Comparisons › JANX vs SBFM

Janux Therapeutics vs Sunshine Biopharma: JANX and SBFM compared

Janux Therapeutics is the larger company: $9.3M of revenue in its latest quarter (Q3 2026) against $9.3M for Sunshine Biopharma (Q2 2026). Sunshine Biopharma is growing faster (-2% against -7% a year earlier). Sunshine Biopharma is more profitable, with an operating margin of -17.4% against -336.5%.

Janux Therapeutics vs Sunshine Biopharma, latest quarterJanux Therapeutics vs Sunshine Biopharma, latest quarterJanux Therapeutics (JANX)Sunshine Biopharma (SBFM)Revenue$9.3M$9.3MRevenue growth, Y/Y-7%-2%Operating margin-336.5%-17.4%Net margin-232.2%-16.9%

Where the money goes: JANX and SBFM

Janux Therapeutics (JANX) · Q3 2026

Janux Therapeutics, Q3 2026: revenue $9.3M (-7% year over year), operating margin -336.5%, net loss $21.6M, operating cash flow −$25.2M. The chart follows the revenue to costs, profit and cash.

Sunshine Biopharma (SBFM) · Q2 2026

Sunshine Biopharma, Q2 2026: revenue $9.3M (-2% year over year), operating margin -17.4%, net loss $1.6M, operating cash flow −$918K. The chart follows the revenue to costs, profit and cash.

Janux Therapeutics (JANX)Sunshine Biopharma (SBFM)
Latest quarterQ3 2026Q2 2026
Revenue$9.3M$9.3M
Revenue growth, Y/Y-7%-2%
Operating margin-336.5%-17.4%
Net earnings−$21.6M−$1.6M
Net margin-232.2%-16.9%
Operating cash flow−$25.2M−$918K
Market value$1.2B—
Analysts’ mean target$32.53—

Questions

Which is bigger, Janux Therapeutics or Sunshine Biopharma?

Janux Therapeutics is the larger company: $9.3M of revenue in its latest quarter (Q3 2026) against $9.3M for Sunshine Biopharma (Q2 2026).

Is Janux Therapeutics or Sunshine Biopharma growing faster?

Sunshine Biopharma is growing faster (-2% against -7% a year earlier).

Which is more profitable, Janux Therapeutics or Sunshine Biopharma?

Sunshine Biopharma is more profitable, with an operating margin of -17.4% against -336.5%.

More: Janux Therapeutics earnings · how Janux Therapeutics makes money · Sunshine Biopharma earnings · how Sunshine Biopharma makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.